Cover Image

The Epidemiology of Antibiotic-Related Adverse Events in the Treatment of Diabetic Foot Infections: A Narrative Review of the Literature

The use of antibiotics for the treatment of diabetic foot infections (DFIs) over an extended period of time has been shown to be associated with adverse events (AEs), whereas interactions with concomitant patient medications must also be considered. The objective of this narrative review was to summ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura Soldevila-Boixader (Author), Oscar Murillo (Author), Felix W. A. Waibel (Author), Tanja Huber (Author), Madlaina Schöni (Author), Rahim Lalji (Author), Ilker Uçkay (Author)
Format:	Book
Published:	MDPI AG, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Local Antibiotics in the Treatment of Diabetic Foot Infections: A Narrative Review
by: Laura Soldevila-Boixader, et al.
Published: (2023)

Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
by: Dominique Altmann, et al.
Published: (2023)

Influence of Skin Commensals on Therapeutic Outcomes of Surgically Debrided Diabetic Foot Infections-A Large Retrospective Comparative Study
by: Ilker Uçkay, et al.
Published: (2023)

Genetic Variations and Antibiotic-Related Adverse Events
by: Nicola Principi, et al.
Published: (2024)

Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making
by: Jerald P. Cherian, et al.
Published: (2024)

Adherence to stewardship recommendations for antibiotic discontinuation reduces antibiotic-associated adverse drug events
by: Patrick Mulligan, et al.
Published: (2024)

Understanding clinician perspectives on antibiotic associated adverse events to inform feedback
by: Jerald Cherian, et al.
Published: (2023)

Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?
by: Rebecca M. Roberts, et al.
Published: (2015)

Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection
by: Laura Soldevila-Boixader, et al.
Published: (2021)

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
by: Ling Shu, et al.
Published: (2024)

Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant <i>Pseudomonas aeruginosa</i> Biofilm
by: Cristina El Haj, et al.
Published: (2024)

Adverse Events of Thread Embedding Acupuncture for the Musculoskeletal Conditions and Diseases: A Narrative Review of Clinical Studies
by: Ji Sun Lee, et al.
Published: (2022)

Immune-related adverse kidney events by immune checkpoint inhibitors; a narrative review on current studies
by: Tella Sadighpour, et al.
Published: (2021)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records
by: Md Muntasir Zitu, et al.
Published: (2023)

Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events
by: WeiQi Li, et al.
Published: (2023)

Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
by: Ranferi Ocaña-Guzmán, et al.
Published: (2023)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Adverse Events Following Immunization
by: L.I. Chernyshova
Published: (2014)

Evaluating adverse events in databases
by: Katie Lovell, et al.
Published: (2023)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022)

Adverse events in diabetic foot infections: a case control study comparing early versus delayed medical treatment after home remedies
by: Cawich SO, et al.
Published: (2014)

Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review
by: Farah Seedat, et al.
Published: (2017)

Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self‐controlled case series analysis
by: Sherrie L. Aspinall, et al.
Published: (2020)

Hyperglycemia, prognosis marker of adverse events in heart attack
by: Yudit García Cairo, et al.
Published: (2014)

Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature
by: Sara Eslait-Olaciregui, et al.
Published: (2023)

NURSES' KNOWLEDGE ABOUT ADVERSE EVENTS AND THE CHALLENGES OF REPORTING THESE EVENTS
by: Jamilly Santos Araujo, et al.
Published: (2016)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2024)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024)

Adverse event signal mining and severe adverse event influencing factor analysis of Lumateperone based on FAERS database
by: Yanjing Zhang, et al.
Published: (2024)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024)

Sarilumab‐induced cutaneous adverse event
by: Sayaka Sato, et al.
Published: (2022)

What Are Adverse Events in Mindfulness Meditation?
by: Dhanesh D. Binda BS, et al.
Published: (2022)

Hospital deaths and adverse events in Brazil
by: Pavão Ana Luiza B, et al.
Published: (2011)

Serious Neurological Adverse Events of Ceftriaxone
by: Clémence Lacroix, et al.
Published: (2021)

ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
by: A. A. Toporov, et al.
Published: (2018)

Response to "Evaluating Adverse Events in Databases"
by: Fabrizio Calapai, et al.
Published: (2023)